AVE 20.0% 0.2¢ avecho biotechnology limited

aod9064 is the real deal.

  1. 10,009 Posts.
    Afternoon POHsters, thanks to Esra and Harry for hosting a shareholders briefing at POH headquarters. Also thanks to Kristen and Paul for their talks and presentations.

    A special thank you to Ijay for taking his time to drive me there. Tangentland runner01,ijay,Makattack and myself had a very informative meeting and tour.

    First and foremost, we covered all the questions put forward and will probably take a few days to post it all for you to read and question further.

    The two highest priority projects for POH at this point are AOD9064 and Oxypatch. The human dose ranging trials are complete and the realist should be announced soon after all the data comes in.

    AOD9064 is on track for market launch in the first half of 2011. This project really has everyone excited. It was good to hear the background information and discuss the science with Paul the head Scientists and the marketing with Kristen the Marketing manager.

    I think all the POHsters who attended are feeling pretty good about both projects are today's meeting. This is the real deal. I don't have time to post indepth just now but the other lads will chime in with their takings on many things discussed.

    Back soon with more.

    PoS
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(20.0%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $2 1.126K

Buyers (Bids)

No. Vol. Price($)
22 34751789 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40153304 27
View Market Depth
Last trade - 12.40pm 08/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.